Huang Ying, Yang Yang, He Yong, Li Jun
School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Mei Shan Road, Hefei, Anhui Province, China, 230032.
The Key Laboratory of Anti-inflammatory and Immune Medicine, Anhui Medical University, Ministry of Education, Hefei, 230032, China.
Tumour Biol. 2015 Dec;36(12):9147-52. doi: 10.1007/s13277-015-4159-7. Epub 2015 Oct 1.
Nemo-like kinase (NLK) is an evolutionarily conserved mitogen-activated protein (MAP) kinase-related kinase that is highly expressed in neural tissues and minimally detected in others. Accumulating evidence demonstrates that NLK exerts a pivotal role in cell proliferation, migration, invasion, and apoptosis via regulation of a variety of transcriptional molecules. The results of recent studies have shown that aberrant expression of NLK is significantly associated with the initiation and progression of various types of human cancers, as well as clinicopathologic features and survival rate. NLK is gradually considered as a potential tumor suppressor or an oncogene depending on the tumor system, and silencing or upregulating of NLK may provide an effective therapeutic approach against tumors. In this review, we will make a summary on the comprehensive roles of NLK in the regulation of various cancers.
尼莫样激酶(NLK)是一种在进化上保守的丝裂原活化蛋白(MAP)激酶相关激酶,在神经组织中高度表达,而在其他组织中检测不到。越来越多的证据表明,NLK通过调节多种转录分子,在细胞增殖、迁移、侵袭和凋亡中发挥关键作用。最近的研究结果表明,NLK的异常表达与各种类型人类癌症的发生和进展以及临床病理特征和生存率显著相关。根据肿瘤系统的不同,NLK逐渐被认为是一种潜在的肿瘤抑制因子或癌基因,沉默或上调NLK可能为肿瘤治疗提供一种有效的方法。在这篇综述中,我们将总结NLK在各种癌症调节中的综合作用。